biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0yd-01a-11d-a10g-09
biospecimen_aliquot__bcr_aliquot_uuid	30c9f9e5-90b2-4c73-bce5-eb6a3d31f496
biospecimen_aliquot__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099016211
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-11-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a10g
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.03
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0yd-01a-11d
biospecimen_analyte__bcr_analyte_uuid	e3f7462f-7da9-44e6-a324-c7ff863c4d34
biospecimen_analyte__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0yd
biospecimen_diagnostic_slides__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	b81ff541-f154-4c49-950b-b6cb723369e2
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0yd
biospecimen_normal_control__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_normal_control__ncedna_dna_conc	0.483
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	41.4
biospecimen_portion__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0yd-01a-11
biospecimen_portion__bcr_portion_uuid	cce1ba47-b839-4ee0-a55c-8ef7d7fc3805
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_portion__date_of_creation	2010-10-18
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0yd-01a-11d
biospecimen_protocol__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_sample__bcr_sample_uuid	08add75d-f706-458a-a6a8-41da7e07af19
biospecimen_sample__days_to_collection	572
biospecimen_sample__initial_weight	740
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0yd.10da3573-bd53-4579-ad90-e770cef08498.pdf
biospecimen_sample__pathology_report_uuid	10da3573-bd53-4579-ad90-e770cef08498
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	34f2f861-7879-47f7-899f-eabcdf52cf0a
biospecimen_shipment_portion__center_id	30
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a21v
biospecimen_shipment_portion__portion_number	41
biospecimen_shipment_portion__portion_sequence	4
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0yd-01a-41-a21v-30
biospecimen_shipment_portion__shipment_portion_day_of_shipment	3
biospecimen_shipment_portion__shipment_portion_month_of_shipment	4
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2012
biospecimen_slide__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0yd-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0yd-01a-01-bsa
biospecimen_slide__bcr_slide_uuid	dbbc3956-3306-4e98-904d-15ed9c0ff148
biospecimen_slide__image_file_name	tcga-a2-a0yd-01a-01-bsa.dbbc3956-3306-4e98-904d-15ed9c0ff148.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	1
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	4
biospecimen_slide__percent_tumor_cells	95
biospecimen_slide__percent_tumor_nuclei	95
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0yd
biospecimen_tumor_sample__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
clinical_drug__bcr_drug_barcode	tcga-a2-a0yd-d5673
clinical_drug__bcr_drug_uuid	39d13e05-d042-4915-a89b-eb9460b38f36
clinical_drug__bcr_patient_barcode	tcga-a2-a0yd
clinical_drug__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
clinical_drug__form_completion_date	2010-12-8
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	136
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	63
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	110
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	440
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0yd-f15770
clinical_follow_up__bcr_followup_uuid	d23505e4-45da-42d1-808a-ca517e53553f
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0yd
clinical_follow_up__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-8-30
clinical_follow_up__last_contact_days_to	769
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	63
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i+)
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t3
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-a2-a0yd
clinical_patient__bcr_patient_uuid	2c6adb12-380d-4710-a7e6-93d5a0e53289
clinical_patient__birth_days_to	-23021
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	90-99%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-12-8
clinical_patient__gender	female
clinical_patient__her2_and_cent17_cells_count	60
clinical_patient__her2_cent17_ratio	1.04
clinical_patient__her2_fish_method	enumerate 60 tumor cells; ratio of her2/centromere 17 >= 2.1 is amplified
clinical_patient__her2_fish_status	negative
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2009
clinical_patient__last_contact_days_to	550
clinical_patient__lymph_nodes_examined_count	2
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a0yd
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	80-89%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YD-01A-11D-A10G-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YD-01A-11D-A10G-09.bed.meta
manually_curated__id	tcga-a2-a0yd-01a-11d-a10g-09
manually_curated__md5sum	588d79185add40e2f37fddf89e701b81
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	30c9f9e5-90b2-4c73-bce5-eb6a3d31f496
manually_curated__tumor_tag	brca
